Getting new medicines for Canadians on the market faster
October 3, 2014 - Montréal, Quebec
In an effort to improve health outcomes for Canadians affected by diseases such as cancer and Alzheimer’s, the National Research Council of Canada is announcing three research programs to help industry get new medicines on the market faster.
From discovery up to clinical trials, the National Research Council will contribute to accelerating the development of new therapeutics and vaccines in collaboration with Canadian and international partners. Research will also focus on delivering therapeutics to the brain, to address diseases of the central nervous system. NRC’s bioprocessing technologies, which enable the production of biologics and vaccines, will be transferred to Canadian contract manufacturing organizations to strengthen the biomanufacturing sector.
Media Relations Team
National Research Council of Canada
Telephone: 613-991-1431
Toll-free: 1-855-282-1637
Email: media@nrc-cnrc.gc.ca
Twitter: @nrc_cnrc
